2016-04-28 15:58:34 UTC

Barrett's Esophagus

Chicago, IL.

Duration

30:16

About

Review of treatments Barret's Esophagus:

Download the session audio:

MP3 File

Download the PowerPoint presentation:

PPT File

About the Instructors

Stuart J. Spechler, MD, AGAF

Stuart Jon Spechler, M.D. is Chief of the Division of Gastroenterology at the VA North Texas Healthcare System, Professor of Medicine, and holder of the Berta M. and Cecil O. Patterson Chair in Gastroenterology at The University of Texas Southwestern Medical Center at Dallas.  Before coming to Dallas in 1997, Dr. Spechler was Director of the Center for Swallowing Disorders at the Beth Israel Deaconess Medical Center and Harvard Medical School.  Dr. Spechler’s clinical and translational research has focused primarily on disorders of the esophagus, especially gastroesophageal reflux disease and its complications including Barrett’s esophagus and esophageal adenocarcinoma. He described the condition known as “short-segment Barrett’s esophagus” in 1994.  He has chaired three VA Cooperative Studies on gastroesophageal reflux disease.  Dr. Spechler has published more than 300 scientific reports, editorials, review articles, and book chapters on esophageal disorders.  He has served on the editorial boards of numerous journals including Gastroenterology, Gut, Alimentary Pharmacology and Therapeutics, and Diseases of the Esophagus.  He is the lead author of the American Gastroenterological Association’s latest technical review and medical position statement on the management of Barrett’s esophagus.

More on Barrett's Esophagus

Late Recurrence of Barrett’s Esophagus After Complete Eradication of Intestinal Metaplasia is Rare: Final Report From Ablation in Intestinal Metaplasia Containing Dysplasia Trial

Sept. 1, 2017

Endoscopic surveillance of patients with BE treated with radiofrequency ablation will likely be of diminishing value as the time since ablation grows.

Cost Effectiveness of Screening Patients With Gastroesophageal Reflux Disease for Barrett’s Esophagus With a Minimally Invasive Cell Sampling Device

Sept. 1, 2017

We found Cytosponge screening with endoscopic confirmation to be a cost-effective strategy.

A Selection of the Best AGA Abstracts of DDW® 2017

July 27, 2017

Read the best AGA abstracts from Digestive Disease Week, published in Gastro.